Display options
Cite
Huber CE, Judex AG, Freyschmidt J, et al. Sequential Combination Therapy Leading to Sustained Remission in a Patient with SAPHO Syndrome. Open Rheumatol J. 2009;3:18-21doi: 10.2174/1874312900903010018.
Huber, C. E., Judex, A. G., Freyschmidt, J., Feuerbach, S., Schölmerich, J., & Müller-Ladner, U. (2009). Sequential Combination Therapy Leading to Sustained Remission in a Patient with SAPHO Syndrome. The open rheumatology journal, 318-21. https://doi.org/10.2174/1874312900903010018
Huber, C E, et al. "Sequential Combination Therapy Leading to Sustained Remission in a Patient with SAPHO Syndrome." The open rheumatology journal vol. 3 (2009): 18-21. doi: https://doi.org/10.2174/1874312900903010018
Huber CE, Judex AG, Freyschmidt J, Feuerbach S, Schölmerich J, Müller-Ladner U. Sequential Combination Therapy Leading to Sustained Remission in a Patient with SAPHO Syndrome. Open Rheumatol J. 2009 Mar 27;3:18-21. doi: 10.2174/1874312900903010018. PMID: 19471601; PMCID: PMC2684709.
Copy Download .nbib Format: NLM
Share it on

Open Rheumatol J. 2009 Mar 27;3:18-21. doi: 10.2174/1874312900903010018.

Sequential Combination Therapy Leading to Sustained Remission in a Patient with SAPHO Syndrome.

The open rheumatology journal

C E Huber, A G Judex, J Freyschmidt, S Feuerbach, J Schölmerich, U Müller-Ladner

Affiliations

  1. Department of Internal Medicine I, University of Regensburg, Regensburg, Germany.

PMID: 19471601 PMCID: PMC2684709 DOI: 10.2174/1874312900903010018

Abstract

The SAPHO syndrome represents a variety of clinically similar disorders with the key features of hyperostotic bone lesions in combination with chronic pustular skin disease. The respective pathophysiology of bone and joint manifestations in SAPHO syndrome is still a matter of discussion. For example it does not appear to represent reactive arthritis and HLA B27 antigen, with the latter being typically present in patients with spondyloarthopathies. Treatment of SAPHO syndrome is also not well established and consists of various antiinflammatory and antirheumatic drugs. Here, we report a female patient with active SAPHO syndrome suffering from sternal swelling of unknown origin that had been known for 10 years and a 4-year-history of severe lower back pain. Remarkable were also a typical pustulous palmar erythema associated with swelling and decreased motility of both MCP-I joints. Inflammation parameters were high with an ESR 68 mm/1st hour and a CRP of 19.6 mg/l. She was initially treated with rofecoxib and doxycycline, followed by sulfasalazine with only partial clinical response. Thereafter, both articular symptoms as well as cutaneous lesions responded well to a combination therapy with methotrexate and sulfasalazine. Thus, the case illustrates nicely that methotrexate in combination with another DMARD can be successfully applied to patients with long-term active SAPHO syndrome.

Keywords: Case report; SAPHO; combination therapy; doxycycline; methotrexate; rofecoxib; sulfasalazine; treatment.

References

  1. Rev Rhum Mal Osteoartic. 1987 Mar;54(3):187-96 - PubMed
  2. Ann Rheum Dis. 1988 Oct;47(10):809-15 - PubMed
  3. J Radiol. 1998 Apr;79(4):337-40 - PubMed
  4. J Rheumatol. 1995 Nov;22(11):2017-9 - PubMed
  5. Semin Arthritis Rheum. 1999 Dec;29(3):159-71 - PubMed
  6. Arthritis Rheum. 1999 Apr;42(4):819-21 - PubMed
  7. Rheum Dis Clin North Am. 1992 Feb;18(1):225-46 - PubMed
  8. Arch Orthop Trauma Surg. 1979 Oct;95(1-2):13-22 - PubMed
  9. Gastroenterol Clin Biol. 1998 Feb;22(2):240-3 - PubMed
  10. Expert Opin Investig Drugs. 2006 Oct;15(10):1229-33 - PubMed
  11. AJR Am J Roentgenol. 1998 Nov;171(5):1431-2 - PubMed
  12. Rheumatology (Oxford). 2008 Aug;47(8):1160-7 - PubMed

Publication Types